XClose

UCL News

Home
Menu

Global Health News

Type 2 diabetes genetic mapping identifies new ‘loci’

Scientists are closer to understanding the genetic causes of type 2 diabetes by identifying 111 new chromosome locations (‘loci’) on the human genome that indicate susceptibility to the disease, according to a UCL-led study in collaboration with Imperial College London.

Publication date:

UCL part of new £100 million Rosalind Franklin Institute

UCL is involved in the Rosalind Franklin Institute (RFI) – a major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre.

Publication date:

Evidence of brain damage found in former footballers

Evidence of chronic traumatic encephalopathy (CTE), a potential cause of dementia caused by repeated blows to the head, has been found in the brains of former association football (soccer) players examined at the UCL Queen Square Brain Bank.

Publication date:

Key friendships vital for effective human social networks

Close friendships facilitate the exchange of information and culture, making social networks more effective for cultural transmission, according to new UCL research that used wireless tracking technology to map social interactions in remote hunter-gatherer populations.

Publication date:

Immune system defence force captured in action

How the natural defence force within our immune system attacks and destroys harmful invaders such as virus-infected and cancerous cells has been visualised in microscopic detail by scientists from UCL, Birkbeck, University of London, Peter MacCallum Cancer Centre and Monash University, Australia.

Publication date:

Light therapy effectively treats early prostate cancer

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.

Publication date:

Mother-child HIV transmission at all time low in UK and Ireland

The number of mothers passing the HIV virus to their babies has fallen to a new record low in the UK and Ireland thanks to the very high take-up of antenatal HIV screening and treatment which reduces virus levels in the pregnant women, according to research led by UCL.

Publication date:

Skipping breakfast and not enough sleep can make children overweight

Mothers smoking in pregnancy, children skipping breakfast and not having a regular bedtime or sufficient sleep all appear to be important factors in predicting whether a child will become overweight or obese, according to new research led by UCL.

Publication date:

UCL economist receives Klaus J. Jacobs Research Prize

The Jacobs Foundation have awarded Professor Orazio Attanasio, Head of UCL Economics and Research Director at the Institute for Fiscal Studies (IFS), 1 million Swiss francs for his use of economic models and field experiments to assess and shape early child development programs and policies in low income countries.

Publication date:

Science begins in the new Francis Crick Institute building

The first scientists have moved into the new £650 million Francis Crick Institute building in London and are starting work in their purpose-built labs. Next to St Pancras station and the British Library, the Crick will be the biggest biomedical research institute under one roof in Europe.

Publication date:

Indian medicine book to be featured on BBC Radio 4

In the Bonesetter’s Waiting Room: Travels through Indian Medicine, the second book by Dr Aarathi Prasad (UCL Grand Challenges), will be BBC Radio 4’s Book of the Week from 23 May.

Publication date:

Resistance to key HIV drug ‘concerningly common’

HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL and funded by the Wellcome Trust.

Publication date:

Early chemotherapy improves survival for men with prostate cancer

Two papers from UCL show that having early chemotherapy improves survival for men with prostate cancer. The papers, published in the Lancet and Lancet Oncology, report the results from the STAMPEDE clinical trial and a meta-analysis.

Publication date: